Rami Levy Marketing-Hashikma Group revenues in 2021 reached NIS 6.45 billion

The Rami Levy Marketing-Hashikma Group published the report for the summary of 2021, which indicates on the one hand a slight decrease in activity in supermarkets, probably due to a return to relative routine after the decline of the corona plague which characterized much more home shopping, and on the other hand a balance of this trend. So the chain ended the year with nice rises in the bottom line.
The Rami Levy Group's revenues in the past year reached NIS 6.45 billion - a negligible decrease of about one third of the percentage compared to NIS 6.47 billion in 2020; Gross profit actually rose, from 1.46 billion to 1.52 billion, and its share of revenues rose from 22.6% to 23.6%; EBITDA increased by 10% from NIS 523 million (8.1%) to 576 million (8.9%); Operating profit increased by 14% to NIS 321 million, compared with NIS 282 million, and its share of total revenues increased from 4.36% to 4.98%; And the net profit rose by 20% to NIS 212 million, compared with NIS 176 million in the first year of the corona plague. It should be noted that the quarterly data were almost identical - a decrease of a fraction of a percent in revenue, but respectable increases in all other indices.
The group noted that its cash register now has NIS 917 million, and its financial debt stands at only NIS 14 million, so it can afford the moves it announced: First, it will distribute a NIS 64 million dividend to investors, who will join the NIS 174 million it distributed After the previous quarterly reports of 2021 and the NIS 1.25 billion it has distributed since its issuance, exactly 15 years ago; And second, it will invest half a billion shekels as part of a "strategic investment that will lead to an increase in the average shopping basket of the company's customers in the company's branches."
Currently, the Rami Levy Group has 56 discount branches, 67 Kopix branches, 266 cafes abroad, 37 branches of Super Kopix and 45 branches of the new Pharm chain Good Pharm; the company noted that in 2021 it reached average sales Of NIS 59,390 per square meter, with its private label accounting for 20% of sales; Its cellular services have 290,000 subscribers, and its credit cards have 260,000 customers.
"In 2021, for the first time, we crossed the NIS 200 million net profit threshold for a single year," said the chain's founder and CEO, Rami Levy. Additional logistics in Marlog and also as a result of a sharp increase in the volume of activity of the subsidiaries, which include the Good-Pharm network, Kopix, the cellular activity and the club.
Levy went on to say that "We continue to adhere to the business strategy and vision from the day the chain opens: to offer the cheapest product basket to the customer, not at the expense of quality and service. This strategy is especially important these days,
Regarding the entry of foreign chains into Israel, Levy said that "we believe that this entry will not harm the company, but on the contrary - it will emphasize the advantages of our network in relation to the consumer and our advantages over suppliers, and also strengthen our private label."